Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in ADCT — ADC Therapeutics SA

CIK 1390777 NEW YORK, NY
Back to ADCT Full portfolio

Position in ADCT

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$269,259
-$489,191 QoQ
Shares Held
251,645
+24.4% QoQ
Ownership
0.197%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 113 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 89% Shared 0% None 11%

Common Shares in ADCT Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $1,289,702,180 across 44 Drug Manufacturers - Specialty & Generic names. ADCT ranks #42 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 3,322,319 $238,741,833
2 VTRS
Viatris Inc
 14,288,053 $226,894,274
3 UTHR
UNITED THERAPEUTICS Corp
 294,413 $159,521,790
4 NBIX
Neurocrine Biosciences Inc
 699,125 $117,830,519
5 ELAN
Elanco Animal Health Inc
 3,411,532 $83,957,795
6 TEVA
Teva Pharmaceutical Industries Ltd
 1,899,912 $64,369,013
7 ALKS
Alkermes plc.
 1,097,282 $57,497,573
8 LNTH
Lantheus Holdings, Inc.
 441,831 $49,016,724

All Filings in ADCT

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $269,259 251,645
2026-03-31 $758,450 202,254
2025-12-31 $610,643 172,987
2025-09-30 $634,776 158,694
2025-06-30 $423,800 158,135
2025-03-31 $224,845 159,466
2024-12-31 $342,264 171,993
2024-09-30 $511,064 162,243
2024-06-30 $648,497 205,221